Simple Summary Kidney cancer is a frequent malignant tumor that accounts for
approximately 5% of all cancer incidences. It affects both males and females, but males are …

Xp11 translocation renal cell carcinoma (tRCC) is a rare, female-predominant cancer driven
by a fusion between the transcription factor binding to IGHM enhancer 3 (TFE3) gene on …

Renal cell carcinoma (RCC) is usually diagnosed in older adults (the median age of
diagnosis is 64 years). Although less common in patients younger than 45 years, RCCs in …

Xp11 translocation renal cell carcinoma (tRCC) is a female-predominant kidney cancer
driven by translocations between the TFE3 gene on chromosome Xp11. 2 and partner …

Purpose To report the clinicopathological features and mid-to long-term oncologic results of
Xp11. 2 translocation/transcription factor E3 (TFE3) gene fusion renal cell carcinomas …

Renal cell carcinoma (RCC) associated with Xp11. 2 translocation/transcription factor E3
(TFE3) gene fusion is a rare subtype of RCC. A 31-year-old male patient was admitted to …

Based on the epidemiological characteristics of susceptibility and age selectivity for women
in Xp11. 2 translocation renal cell carcinoma (Xp11. 2 tRCC), we inferred that estrogen was …

Objectives To investigate the sonographic features in Xp11. 2 translocation renal cell
carcinoma (Xp11. 2 tRCC) using both conventional ultrasound (US) and contrast‐enhanced …

Background Xp11. 2 translocation renal cell carcinoma (tRCC) is defined by translocation of
the transcription factor E3 (TFE3) gene located on chromosome Xp11. 2. Due to the high …

Background: MED15-TFE3 renal cell carcinoma is a rare subtype of the Xp11 translocation
renal cell carcinoma. To data, only 14 cases of MED15-TFE3 renal cell carcinoma have …